Related references
Note: Only part of the references are listed.ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
Yaolu Wei et al.
FRONTIERS IN ONCOLOGY (2022)
EMT, cancer stem cells and autophagy; The three main axes of metastasis
Ghader Babaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma
Wen Zhang et al.
BMC MEDICINE (2021)
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression
Cuicui Liu et al.
CANCER RESEARCH (2021)
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
Eva Obermayr et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Metastasis-Initiating Cells and Ecosystems
Joan Massague et al.
CANCER DISCOVERY (2021)
Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma
Yongrong Lei et al.
FRONTIERS IN ONCOLOGY (2021)
Circulating tumor cells: biology and clinical significance
Danfeng Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher et al.
FRONTIERS IN IMMUNOLOGY (2020)
Technologies for circulating tumor cell separation from whole blood
Petra Banko et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-time Blood Drawing
Pei-Hung Chang et al.
CANCERS (2019)
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
Areti Strati et al.
CELLS (2019)
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
Chun-Hui Lee et al.
BMC CANCER (2019)
Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
Maria A. Papadaki et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients
Y. Ning et al.
PHARMACOGENOMICS JOURNAL (2018)
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma
Wei Guo et al.
CLINICAL CANCER RESEARCH (2018)
The viable circulating tumor cells with cancer stem cells feature, where is the way out?
Y. T. Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Katherine E. Poruk et al.
CLINICAL CANCER RESEARCH (2017)
Prognostic value of CD133+CD54+CD44+ circulating tumor cells in colorectal cancer with liver metastasis
Chao Fang et al.
CANCER MEDICINE (2017)
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Linda O'Flaherty et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Circulating Tumor Cells and Cancer Stem Cells: Clinical Implications in Nonmetastatic Breast Cancer
M. Sayed et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2016)
Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer
Kun Chang et al.
ONCOTARGET (2015)
Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
Patrick Weller et al.
PLOS ONE (2014)
Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer
Man Li et al.
BIOMED RESEARCH INTERNATIONAL (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Expression of Intercellular Adhesion Molecule 1 by Hepatocellular Carcinoma Stem Cells and Circulating Tumor Cells
Shupeng Liu et al.
GASTROENTEROLOGY (2013)
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
Kornelius Schulze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer
G. Pirozzi et al.
ONCOLOGY REPORTS (2013)
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
A. Gradilone et al.
ANNALS OF ONCOLOGY (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
GRADE guidelines: 7. Rating the quality of evidence-inconsistency
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
Hisae Iinuma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Circulating Tumor Cells: Not All Detected Cells Are Bad and Not All Bad Cells Are Detected
Max S. Wicha et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells
Zeshaan A. Rasheed et al.
STEM CELLS (2011)
Clinical relevance and biology of circulating tumor cells
Natalia Bednarz-Knoll et al.
BREAST CANCER RESEARCH (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
Paola Gazzaniga et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)